The leadership of Nigeria Employers Consultative Association (NECA) and National Union of Food, Beverages, Tobacco Employees (NUFBTE) have raised alarm over
THERE is palpable tension and apprehension among Nigerians over plans by Sanofi-Aventis Nigeria Ltd, major manufacturers of polio vaccines in Nigeria, to
Biological E India s next Serum, Bharat Biotech of COVID-19 vaccine
The acquisition of Akorn India helped Biological E create a potential overall manufacturing capacity of over 1 billion doses per annum.
PB Jayakumar | June 2, 2021 | Updated 23:07 IST
Providence will provide necessary technology transfer for Biological E to manufacture mRNA vaccines in India.
The oldest Indian private vaccine maker, Hyderabad-based Biological E Limited, is emerging as a domestic powerhouse of COVID-19 vaccine manufacturing following its latest deal with Canada-based biotech company Providence Therapeutics.
In addition to the Providence deal, Biological E currently has a couple of in-house COVID-19 vaccines under development and another major manufacturing contract agreement for Johnson & Johnson s single-dose COVID-19 vaccine. It was among the earliest Indian companies to tap potential COVID-19 vaccine opportunities.